Phase III, Randomized, Double-blind, Placebo controlled trial of Efficacy, Safety and Tolerability of Antiviral drug Umifenovir vs Standard care of therapy in non-severe COVID-19 patients.
Ramachandran R, Bhosale V, Reddy H, Atam V, Faridi M, Fatima J, Shukla V, Khan ZA, Khan H, Singh V, Negi MPS, Srivastava M, Srivastava AK, Tripathi CB, Ghosh N, Majumdar N, Tripathi RK, Rath SK, Mishra PR, Sharma S, Kundu TK.
Ramachandran R, et al. Among authors: negi mps.
Int J Infect Dis. 2022 Feb;115:62-69. doi: 10.1016/j.ijid.2021.11.025. Epub 2021 Nov 19.
Int J Infect Dis. 2022.
PMID: 34801738
Free PMC article.
Clinical Trial.